| Similar Articles |
|---|
 |
The Motley Fool
August 15, 2008
Brian Orelli |
Syneron Medical's Bipolar Growth While U.S. sales sink, international sales are keeping the medical laser making company afloat.   |
The Motley Fool
November 11, 2008
Brian Orelli |
Two Years of Red Aesthetic laser makers have been rocked over the last few years. |
The Motley Fool
December 7, 2006
Matt Koppenheffer |
The Best Small Cap for 2007: Syneron This Israel-based aesthetic laser company has financials that need no cosmetic touch-ups. Investors, take note. |
The Motley Fool
May 15, 2008
Brian Orelli |
So-So Syneron A little growth is an acceptable outcome in the struggling medical laser industry. |
The Motley Fool
April 10, 2007
Rich Duprey |
The Beauty of Lasers With aesthetic laser treatments booming, which company looks the best? Candela... Cutera... Palomar Medical Technologies... Cynosure... Syneron... |
The Motley Fool
February 4, 2008
Kristin Graham |
Best International Stock: Syneron Medical A quick summary of Israeli medical device maker Syneron, a company that could keep you and your portfolio both looking young and healthy. |
The Motley Fool
May 12, 2006
Rich Duprey |
Cutera Continues to Burn The aesthetic laser maker is at risk of losing a patent lawsuit against a competitor. Investors, patents by themselves should not be considered a sufficient competitive moat to induce investment in a company. |
The Motley Fool
May 8, 2007
Rich Duprey |
Cutera's Ugly Quarter The aesthetic laser maker's weak domestic sales dim the outlook for the rest of the year. Investors, take note. |
The Motley Fool
February 28, 2007
Matt Koppenheffer |
P&G to Help Syneron Smooth Its Customers The consumer-goods giant teams up with the small cap to treat consumers' skin. The real question for investors, though, is how these new products will impact the company's financials. |
The Motley Fool
April 24, 2008
Rich Duprey |
Candela Fizzles Aesthetic laser maker Candela reports slightly higher revenue but wider-than-anticipated losses. |
The Motley Fool
June 14, 2005
Stephen D. Simpson |
Syneron Aims for Cellulite An FDA approval gives Israel's Syneron the lead in non-surgical cellulite treatment. With robust profit margins, that additional revenue could make a big impact on the bottom line. Investors, take note. |
The Motley Fool
April 30, 2007
Rich Duprey |
Foolish Forecast: Cutera Zaps Quarter Investors, don't expect the aesthetic laser maker to burn up the growth charts when it reports first-quarter results. |
The Motley Fool
May 15, 2006
Stephen D. Simpson |
Sales and Marketing Slam Syneron Higher expenses and disappointing results leave the med-tech stock suffering. |
The Motley Fool
February 13, 2007
Rich Duprey |
Palomar's Parallax View A plethora of one-time revenues skewed the aesthetic laser maker's results. Investors, take note. |
The Motley Fool
February 13, 2006
Stephen D. Simpson |
Will Syneron Defy History? Publicly traded laser companies have a legacy of failure; will Syneron manage to turn that tide? |
The Motley Fool
January 10, 2006
Rich Duprey |
Biolase Brightens Outlook The aesthetic laser company expects to be cash flow-neutral on flat revenues. Investors cheer. |
The Motley Fool
March 14, 2008
Rich Duprey |
No Point Man at Candela Activist hedge fund Third Point cuts its stake in the aesthetic laser maker Candela from 9% to only 3.5%. |
The Motley Fool
April 9, 2007
Rich Duprey |
Cutera's Meltdown The maker of aesthetic lasers lowers guidance, and Mr. Market's reaction isn't surprising. |
The Motley Fool
February 4, 2008
Dave Mock |
About the Quarter, RF Micro ... Although RF Micro Devices warns investors in advance that third-quarter results weren't going to be pretty, they still hurt to hear. But, is the worst over for the chip maker? |
The Motley Fool
January 14, 2008
Dave Mock |
RF Micro: Different Reason, Same Result The stock of radio frequency semiconductor supplier RF Micro was slammed, after the company warned that its third-quarter financials won't live up to expectations. |
The Motley Fool
February 14, 2006
Rich Duprey |
Cutera's Laser Woes Aesthetic laser maker has a cloudy future of lower sales, earnings, and patent lawsuits. Investors, take note. |
The Motley Fool
January 3, 2005
Rich Smith |
No News Is Great News Microcaps are volatile; for the patient investor, that can be a good thing. |
The Motley Fool
February 11, 2005
Stephen D. Simpson |
Laser Beamer Lookin' Good Palomar continues to build a profitable business in the highly competitive cosmetic laser market. |
